ATE357933T1 - Formulierungen von quinapril und verwandte ace- hemmer - Google Patents
Formulierungen von quinapril und verwandte ace- hemmerInfo
- Publication number
- ATE357933T1 ATE357933T1 AT03729543T AT03729543T ATE357933T1 AT E357933 T1 ATE357933 T1 AT E357933T1 AT 03729543 T AT03729543 T AT 03729543T AT 03729543 T AT03729543 T AT 03729543T AT E357933 T1 ATE357933 T1 AT E357933T1
- Authority
- AT
- Austria
- Prior art keywords
- formulations
- quinapril
- earth metal
- ace inhibitors
- metal carbonate
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000005541 ACE inhibitor Substances 0.000 title abstract 2
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 title abstract 2
- JSDRRTOADPPCHY-HSQYWUDLSA-N quinapril Chemical compound C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CC2=CC=CC=C2C1)C(O)=O)CC1=CC=CC=C1 JSDRRTOADPPCHY-HSQYWUDLSA-N 0.000 title abstract 2
- 229960001455 quinapril Drugs 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 3
- 229910052784 alkaline earth metal Inorganic materials 0.000 abstract 2
- -1 alkaline-earth metal carbonate Chemical class 0.000 abstract 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 abstract 1
- 150000007514 bases Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000000890 drug combination Substances 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IS6233 | 2002-01-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE357933T1 true ATE357933T1 (de) | 2007-04-15 |
Family
ID=36701209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03729543T ATE357933T1 (de) | 2002-01-15 | 2003-01-14 | Formulierungen von quinapril und verwandte ace- hemmer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20050118259A1 (de) |
| EP (1) | EP1513555B1 (de) |
| AT (1) | ATE357933T1 (de) |
| AU (1) | AU2003235579A1 (de) |
| DE (1) | DE60312857T2 (de) |
| EA (1) | EA007981B1 (de) |
| ES (1) | ES2283774T3 (de) |
| IS (1) | IS2440B (de) |
| UA (1) | UA78542C2 (de) |
| WO (1) | WO2003059388A1 (de) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005027881A2 (en) * | 2003-09-23 | 2005-03-31 | Texcontor Etablissement | Stable quinapril compositions |
| WO2005067887A2 (en) * | 2004-03-24 | 2005-07-28 | Actavis Group | Formulations of ramipril |
| PT1729739T (pt) * | 2004-03-29 | 2016-12-01 | Servier Lab | Processo para a preparação de uma composição farmacêutica sólida |
| SI21800A (sl) | 2004-05-14 | 2005-12-31 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Nov postopek sinteze perindoprila |
| GB0518129D0 (en) * | 2005-09-06 | 2005-10-12 | Arrow Int Ltd | Ramipril formulation |
| GB2431579A (en) * | 2005-10-28 | 2007-05-02 | Arrow Int Ltd | Ramipril formulations |
| US20070098782A1 (en) * | 2005-10-28 | 2007-05-03 | Selamine Limited | Ramipril Formulation |
| ES2523729T3 (es) | 2006-06-16 | 2014-12-01 | Lek Pharmaceuticals D.D. | Composición farmacéutica que comprende hidroclorotiazida y telmisartán |
| GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
| GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
| GB0624082D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril metal salts |
| GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
| WO2008132756A1 (en) * | 2007-05-01 | 2008-11-06 | Lupin Limited | Stable pharmaceutical compositions of ramipril |
| TR200906322A2 (tr) | 2009-08-17 | 2011-07-21 | Bi̇lgi̇ç Mahmut | Çözünürlük ve stabilite özellikleri geliştirilmiş granüller. |
| PL227900B1 (pl) | 2012-11-15 | 2018-01-31 | Adamed Spolka Z Ograniczona Odpowiedzialnoscia | Kompozycja farmaceutyczna zawierająca inhibitor ACE i bloker kanałów wapniowych, sposób jej wytwarzania i jednostka dawkowania zawierająca tę kompozycję |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743450A (en) * | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
| HU222489B1 (hu) * | 1990-07-25 | 2003-07-28 | Novartis Ag. | Stabilizált gyógyszerkészítmények és eljárás az előállításukra |
| US5292520A (en) * | 1990-09-13 | 1994-03-08 | Akzo N.V. | Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer |
| US5573780A (en) * | 1995-08-04 | 1996-11-12 | Apotex Usa Inc. | Stable solid formulation of enalapril salt and process for preparation thereof |
| EP1083931B1 (de) * | 1998-06-05 | 2005-05-11 | Warner-Lambert Company LLC | Stabilisierung von zusammensetzungen enthaltend ace-hemmer durch magnesiumoxid |
| JP2002529405A (ja) * | 1998-11-06 | 2002-09-10 | ジー・ディー・サール・アンド・カンパニー | 心臓血管系疾患による発病率及び死亡率減少のためのアンギオテンシン変換酵素阻害薬及びアルドステロン拮抗薬の併用療法 |
| RU2165251C1 (ru) * | 2000-09-06 | 2001-04-20 | Федеральное государственное унитарное предприятие Московское производственное химико-фармацевтическое объединение им. Н.А. Семашко | Твердая лекарственная форма эналаприла и способ ее получения |
-
2003
- 2003-01-14 EA EA200400942A patent/EA007981B1/ru not_active IP Right Cessation
- 2003-01-14 DE DE60312857T patent/DE60312857T2/de not_active Expired - Lifetime
- 2003-01-14 ES ES03729543T patent/ES2283774T3/es not_active Expired - Lifetime
- 2003-01-14 UA UA20040806559A patent/UA78542C2/uk unknown
- 2003-01-14 WO PCT/IS2003/000002 patent/WO2003059388A1/en not_active Ceased
- 2003-01-14 EP EP03729543A patent/EP1513555B1/de not_active Expired - Lifetime
- 2003-01-14 AU AU2003235579A patent/AU2003235579A1/en not_active Abandoned
- 2003-01-14 AT AT03729543T patent/ATE357933T1/de not_active IP Right Cessation
- 2003-01-14 US US10/501,454 patent/US20050118259A1/en not_active Abandoned
-
2004
- 2004-08-11 IS IS7394A patent/IS2440B/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20050118259A1 (en) | 2005-06-02 |
| AU2003235579A1 (en) | 2003-07-30 |
| EA007981B1 (ru) | 2007-02-27 |
| DE60312857D1 (de) | 2007-05-10 |
| ES2283774T3 (es) | 2007-11-01 |
| EA200400942A1 (ru) | 2004-12-30 |
| IS7394A (is) | 2004-08-11 |
| UA78542C2 (en) | 2007-04-10 |
| EP1513555A1 (de) | 2005-03-16 |
| WO2003059388A1 (en) | 2003-07-24 |
| DE60312857T2 (de) | 2008-01-17 |
| IS2440B (is) | 2008-11-15 |
| EP1513555B1 (de) | 2007-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60312857D1 (de) | Formulierungen von quinapril und verwandte ace-hemmer | |
| TR200103186T2 (tr) | MEK enzimlerinin inhibitörleri olarak kinolin türevleri | |
| WO2004005281A8 (en) | Inhibitors of tyrosine kinases | |
| WO2003080070A3 (en) | Combination comprising an hmg-coa reductase inhibittor and an insulin secretor enhancer or an insulin sensitizer | |
| DE60316552D1 (de) | Tablette mit hohem wirkstoffgehalt | |
| GEP20084485B (en) | Matrix for sustained, invariant and independent release of active compounds | |
| SE0202463D0 (sv) | Novel compounds | |
| WO2001078680A3 (en) | Pharmaceutical compositions comprising fluvastatin | |
| EE200200086A (et) | Reniin-angiotensiini süsteemi inhibiitori kasutamine, kombineeritud produkt ja meetod kardiovaskulaarsete haigusjuhtude ärahoidmiseks | |
| AR038527A1 (es) | Forma de dosificacion que contiene un inhibidor de la pde 4 como ingrediente activo | |
| EP1346732A3 (de) | Dosierungformen hygroskopisch aktiver Inhaltstoffe | |
| DK1608346T3 (da) | Lægemiddeltilförselssammensætninger af alfa-hydroxysyreester og fremgangsmåder til anvendelse heraf | |
| BRPI0517916A (pt) | comprimido que compreende um sal de carbonato de um polìmero de amina alifática, composições e método para remover fosfato de um paciente com necessidade do mesmo | |
| EA201001083A1 (ru) | Композиция таблетки пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение | |
| CY1111698T1 (el) | Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης | |
| TR200401793T4 (tr) | Perindopril tuzu ve bunu içeren farmasötik bileşimler. | |
| WO2006050236A3 (en) | Compounds and methods of use thereof | |
| TW200609005A (en) | Film-coated tablet with plural coating-layers | |
| MY133322A (en) | Storage stable tablets of fosinopril sodium | |
| BR0306928A (pt) | Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace) | |
| TW200509919A (en) | Cathepsin S inhibitors | |
| MXPA05011497A (es) | Derivados de tropano y su uso como inhibidores de la enzima de conversion de angiotensina (ace). | |
| WO2006071844A8 (en) | Oxygen-impervious packaging and methods for storing thyroid hormone | |
| DK1613571T3 (da) | Deutererede catecholaminderivater og lægemidler indeholdende disse forbidelser | |
| DK1200088T3 (da) | Sammensætning indeholdende paracetamol og drotaverin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |